High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica.
High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica.
复制标题
血清和脑脊液中硫酸乙酰肝素和透明质酸的高水平可能是视神经脊髓炎严重程度的生物标志物。
DOI:
10.3389/fimmu.2021.705536
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Wang H
中科院分区:
文献类型:
--
作者:
Zhang Q;Pei S;Zhou Z;Wang Z;Peng Y;Chen J;Wang H
Background Neuromyelitis optica (NMO), multiple sclerosis (MS) and autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy are idiopathic inflammatory demyelinating diseases (IIDDs) that mainly present as encephalomyelitis. Heparan sulfate (HS) and hyaluronic acid (HA) are two components of glycocalyx, a carbohydrate-rich layer on the surface of blood vessels that mediates interaction with blood. Degradation of glycocalyx in NMO is poorly understood. Purpose To detect the serum and cerebrospinal fluid (CSF) levels of shed HS and HA and to correlate these levels with disease severity to determine their diagnostic value. Methods We obtained serum and CSF samples from 24 NMO patients, 15 MS patients, 10 autoimmune GFAP astrocytopathy patients, and 18 controls without non-inflammatory neurological diseases. Soluble HS and HA, and IFNγ, IL17A, and matrix metalloproteinase (MMP) 1 were detected via ELISA. Results Serum and CSF levels of HS, HA and related cytokines but not of plasma MMP1 were significantly elevated in these diseases. Notably, HS and HA levels were positively correlated with Expanded Disability Status Scale scores. Conclusions Our results indicate glycocalyx degradation and inflammation in NMO, MS and autoimmune GFAP astrocytopathy. Moreover, increased shedding of HS or HA may indicate a worse clinical situation. Furthermore, therapeutic strategies that protect glycocalyx may be effective in these diseases.
登录
查看更多内容
影响因子:
7.3
作者:
Platt MP;Agalliu D;Cutforth T
通讯作者:
Cutforth T
影响因子:
4.5
作者:
Reitsma, Sietze;Slaaf, Dick W.;Vink, Hans;van Zandvoort, Marc A. M. J.;Egbrink, Mirjam G. A. oude
通讯作者:
Egbrink, Mirjam G. A. oude
DOI:
10.1152/ajpheart.00090.2018
发表时间:
2019-03-01
影响因子:
4.8
作者:
Ali, Mohamed M.;Mahmoud, Abeer M.;Phillips, Shane A.
通讯作者:
Phillips, Shane A.
影响因子:
5.3
作者:
Liu, Zhuhe;Chen, Jinyu;Peng, Yu
通讯作者:
Peng, Yu
影响因子:
3.3
作者:
Setiadi, A. Francesca;Abbas, Alexander R.;Townsend, Michael J.
通讯作者:
Townsend, Michael J.